All reagents were used as received unless otherwise noted. Solvents were purified under nitrogen using a solvent purification system (Innovative Technology, Inc. Model # SPS-400-3 and PS-400-3). Tris(dibenzylideneacetone)-dipalladium (Pd 2 dba 3 ) was purchased from Sigma Aldrich and was stored in a glovebox (for conditions A, table 1) and on the benchtop (for conditions B, table 1). Cyclohexylallene was purchased (Sigma-Aldrich) and (propa-1,2-dien-1-yloxy)methyl)benzene was synthesized by isomerization of the respective propargyl ether, according to previously published methods.
All reagents were used as received unless otherwise noted. Solvents were purified under nitrogen using a solvent purification system (Innovative Technology, Inc. Model # SPS-400-3 and PS-400-3). Tris(dibenzylideneacetone)-dipalladium (Pd 2 dba 3 ) was purchased from Sigma Aldrich and was stored in a glovebox (for conditions A, table 1) and on the benchtop (for conditions B, table 1). Cyclohexylallene was purchased (Sigma-Aldrich) and (propa-1,2-dien-1-yloxy)methyl)benzene was synthesized by isomerization of the respective propargyl ether, according to previously published methods. 1 All remaining allenes were synthesized from the respective 1-alkyne precursors according to established procedures. 2 All reactions were conducted under an atmosphere of nitrogen with magnetic stirring in flame-dried or oven-dried (120 ˚C) glassware. Ligand 5b (IPr* OMe ) was purchased from Strem and was stored in a glovebox and 5b·HBF 4 (IPr* OMe ·HBF 4 ) was synthesized according to known methods and stored on the benchtop in a dessicator. 3 NHC Ligands 3b (DM-IMes·HCl), 4b (DM-IPr·HCl), and 5a (IPr*·HCl) were synthesized according to established methods and were stored and weighed out in a glovebox. 4 All other utilized N-heterocyclic carbene salts (3a and 4a) and t-BuOK (purchased from Sigma-Aldrich and Strem) were stored and weighed in an inert atmosphere glovebox. Triethylsilane (purchased from Sigma-Aldrich) was passed through alumina and degassed before use. Benzyldimethylsilane (purchased from SigmaAldrich) and dimethylphenylsilane (purchased from Sigma-Aldrich) were used as received. Dimethylethoxysilane (purchased from Acros) was stored in a Schlenk flask. Iodobenzene, 1-iodo-4-nitrobenzene, 4-iodoacetophenone, 4-iodoanisole, 5-iodo-1,3-dimethyluracil, 2-iodothiophene, 1-(4-iodophenyl)pyrrole, 2-iodotoluene and 6-iodo-2,4-dihydrobenzo[b] [1, 4] dioxine were used as received and purchased from Sigma-Aldrich. Allylsilanes 2a and 2b were afforded by previously reported procedures. 5 A solution of tetra-n-butylammonium (TBAF, 1.0 M in THF, purchased from Sigma-Aldrich). 1 H and 13 C spectra were obtained in CDCl 3 at rt (25 ˚C), unless otherwise noted, on a Varian Mercury 400 MHz instrument, Varian Unity 500 MHz instrument, or Varian Unity 700 MHz instrument. Chemical shifts of 1 H NMR spectra were recorded in parts per million (ppm) on the δ scale from an internal standard of residual chloroform (7.24 ppm). Chemical shifts of 13 C NMR spectra were recorded in ppm from the central peak of CDCl 3 (77.0 ppm) on the δ scale. High-resolution mass spectra (HRMS) were obtained on a VG-70-250-s spectrometer manufactured by Micromass Corp. (Manchester UK) at the University of Michigan Mass Spectrometry Laboratory. Regioisomeric ratios were determined on crude reaction mixtures using NMR or GC. GC analyses were carried out on an HP 6980 Series GC System with HP-5MS column (30 m x 0.252 mm x 0.25 µm). When noted, a Biotage purification system (model # SP1) was utilized with SNAP (10 g) S2 silica columns. Reported regioselectivities were determined by GCMS analysis and confirmed by 1 H NMR analysis by comparing the ratios of detectable geminal protons of the major and minor regioisomers in the crude reaction mixture. In cases where >98:2 regioselectivity is reported, minor isomers were not detected by either GCMS or NMR based methods.
General procedure I for the Pd 2 dba 3 /IPr* OMe -promoted hydrosilylation of monosubstituted allenes (table 1): THF (1.0 mL) was added to a solid mixture of IPr* OMe 5b (0.03 mmol) and Pd 2 dba 3 (0.015 mmol) at rt. After stirring for 10 min at rt, the reaction mixture turned dark red, and silane (0.3 mmol) was added. The reaction mixture was stirred for 10 min at rt followed by dilution with THF (4.0 mL) and addition of the allene (0.3 mmol) neat by syringe. The reaction mixture was stirred at rt for 2 h. The reaction mixture was filtered through silica gel eluting with 50 % v/v EtOAc/hexanes. The solvent was removed in vacuo, and the crude residue was purified via flash column chromatography on silica gel or by Biotage to afford the desired product.
General procedure II for the Pd 2 dba 3 /IPr* OMe -promoted hydrosilylation of monosubstituted allenes (conditions A, table 2): THF (1.0 mL) was added to a solid mixture of IPr* OMe 5b (0.015 mmol) and Pd 2 dba 3 (0.0075 mmol) at rt. After stirring for 10 min at rt, the reaction mixture turned dark red, and silane (0.3 mmol) was added. The reaction mixture was stirred for 10 min at rt followed by dilution with THF (4.0 mL) and addition of the allene (0.3 mmol) neat by syringe. The reaction mixture was stirred at rt for 2 h. The reaction mixture was filtered through silica gel eluting with 50 % v/v EtOAc/hexanes. The solvent was removed in vacuo, and the crude residue was purified via flash column chromatography on silica gel or by Biotage to afford the desired product. IPr* OMe ·HBF 4 5b (0.025 mmol), t-BuOK (0.025 mmol), and Pd 2 dba 3 (0.0125 mmol) were added to a 6.0 mL dram vial in air. The vial was fitted with a septum and underwent 3 pump/purge manifold cycles with nitrogen. THF (1.0 mL) was then added to the solid mixture. After stirring for 10 min at rt, the reaction mixture turned dark red, and silane (0.5 mmol) was added. The reaction mixture was stirred for 10 min at rt followed by addition of the allene (0.5 mmol) neat by syringe. The reaction mixture was stirred at rt for 30 min. The reaction mixture was filtered through silica gel eluting with 50 % v/v EtOAc/hexanes. The solvent was removed in vacuo, and the crude residue was purified via flash column chromatography on silica gel or by Biotage to afford the desired product. 
General

Dimethyl(phenyl)(3-phenylprop-1-en-2-yl)silane (6a) (Table 2, Entry 3)
General procedure II was followed with Pd 2 dba 3 (6.9 mg, 0.0075 mmol), IPr* OMe 5b (14.2 mg, 0.015 mmol), dimethylphenylsilane (46 µL, 0.3 mmol), and phenylallene (34.9 mg, 0.3 mmol). The crude residue was purified by Biotage system (100% hexanes) affording a clear oil (63 mg, 83 %). Spectral data matched that previously reported. 
Ethoxydimethyl(3-phenylprop-1-en-2-yl)silane (6b) (Table 2, Entry 4)
Conditions A: General procedure II was followed with Pd 2 dba 3 (6.9 mg, 0.0075 mmol), IPr*
OMe 5b (14.2 mg, 0.015 mmol), dimethylethoxysilane (31.2 mg, 0.3 mmol), and phenylallene (34.9 mg, 0.3 mmol). The crude residue was purified by flash chromatography (5 % v/v EtOAc/hexanes) affording a clear oil (58 mg, 88 %). Full characterization for the major product (6b) is provided below ( 
Benzyldimethyl(3-phenylprop-1-en-2-yl)silane (6c) (Table 2, Entry 5)
OMe 5b (14.2 mg, 0.015 mmol), benzyldimethylsilane (47.5 µL, 0.3 mmol), and phenylallene (34.9 mg, 0.3 mmol). The crude residue was purified by flash chromatography (100% hexanes) affording a clear oil (71 mg, 90 %). Full characterization for the major product (6c) is provided below ( THF (25 mL) was added to a solid mixture of IPr* OMe 5b (321 mg, 0.34 mmol) and Pd 2 dba 3 (156 mg, 0.17 mmol) at rt. After stirring for 5 min at rt, the reaction mixture turned bright red and dimethylphenylsilane (1.0 mL, 6.8 mmol) was added. The reaction mixture was stirred for 10 min at rt followed by dilution with THF (75 mL) and addition of (propa-1,2-dien-1-yloxy)methyl)benzene (1.0 g, 6.8 mmol) neat by syringe. The reaction mixture was stirred at rt for 2 h. The reaction mixture was filtered through silica gel eluting with 50% v/v EtOAc/hexanes. The solvent was removed in vacuo, and the crude residue was purified via flash column chromatography (10% v/v EtOAc/hexanes) on silica gel to afford the desired product as a yellow oil (1.8 g, 95%). Spectral data matched that previously published ( 1 H NMR spectrum is included below). 
Ethoxydimethyl(undec-1-en-2-yl)silane (8b) (Table 2, Entry 10)
General procedure II was followed with Pd 2 dba 3 (6.9 mg, 0.0075 mmol), IPr* OMe 5b (14.2 mg, 0.015 mmol), dimethylethoxysilane (47.5 µL, 0.3 mmol), and undeca-1,2-diene (45.7 mg, 0.3 mmol). The crude residue was purified by flash chromatography (10 % v/v EtOAc/hexanes) affording a clear oil (67 mg, 87 %) (with 96:4 regioselectivity). 1 
Benzyldimethyl(undec-1-en-2-yl)silane (8c) (Table 2, Entry 11)
General procedure II was followed with Pd 2 dba 3 (6.9 mg, 0.0075 mmol), IPr* OMe 5b (14.2 mg, 0.015 mmol), benzyldimethylsilane (47.5 µL, 0.3 mmol), and undeca-1,2-diene (45.7 mg, 0.3 mmol). The crude residue was purified by flash chromatography (100% hexanes) affording a clear oil (82.6 mg, 91%) (with 93:7 regioselectivity). 1 , and t-BuOK (0.025 mmol) were added to a 6.0 mL dram vial in air. The vial was fitted with a septum and underwent 3 pump/purge manifold cycles with nitrogen. THF (1.0 mL) was then added to the solid mixture. After stirring for 10 min at rt, the reaction mixture turned dark red, and silane (0.5 mmol) was added. The reaction mixture was stirred for 10 min at rt followed by addition of the allene (0.5 mmol) neat by syringe. The reaction mixture was stirred at rt until reaction was determined complete by disappearance of starting material, within 30 min, as observed by thin-layer chromatography. TBAF (1 mmol, 2.0 equiv., 1.0 M in THF) was then added slowly by hand with a syringe over 5 minutes (caution, a strong exotherm is generated!) to the stirring solution. After 10 min at rt, the iodide (0.5 mmol) was added followed by Pd 2 dba 3 (0.0125 mmol). The reaction vessel was then heated at 50 °C in an oil bath until the reaction was determined complete by the disappearance of iodide, within 30 min, as determined by thin-layer chromatography. The solvent was removed in vacuo, and the crude residue was purified via flash column chromatography on either silica gel or by Biotage purification system to afford the desired product. (11.4 mg, 0.025 mmol) . The crude residue was purified by flash chromatography (100% hexanes) affording a clear oil (85 mg, 85 %). Spectral data matched that previously reported ( 1 H NMR spectrum is included below). 
H NMR (400
1-(4-(3-Cyclohexylprop-1-en-2-yl)phenyl)ethan-1-one (11) (Table 3, Entry 4)
General procedure IV was followed with Pd 2 dba 3 (11.4 mg, 0.025 mmol), IPr* OMe ·HBF 4 5b (25.8 mg, 0.025 mmol), t-BuOK (2.8 mg, 0.025 mmol), dimethylethoxysilane (68.8 µL, 0.5 mmol), cyclohexylallene (72.7 µL, 0.5 mmol), 4-iodoacetophenone (123 mg, 0.5 mmol), TBAF (1 mL, 1 mmol), and a second batch of Pd 2 dba 3 (11.4 mg, 0.025 mmol). The crude residue was purified by flash chromatography (20 % v/v EtOAc/hexanes) affording a clear oil (110 mg, 90 %). Spectral data matched that previously reported ( 1 H NMR spectrum is included below). 
S10
General procedure IV was followed with Pd 2 dba 3 (11.4 mg, 0.025 mmol), IPr* OMe ·HBF 4 5b (25.8 mg, 0.025 mmol), t-BuOK (2.8 mg, 0.025 mmol), dimethylethoxysilane (68.8 µL, 0.5 mmol), cyclohexylallene (72.7 µL, 0.5 mmol), 4-iodoanisole (117 mg, 0.5 mmol), TBAF (1 mL, 1 mmol), and a second batch of Pd 2 dba 3 (11.4 mg, 0.025 mmol). The crude residue was purified by flash chromatography (100% hexanes) affording a clear oil (85 mg, 74 %). Spectral data matched that previously reported ( 1 H NMR spectrum is included below). 10 Cyclohexylprop-1-en-2-yl)-1,3-dimethylpyrimidine-2,4(1H,3H) 
5-(3-
2-(3-Cyclohexylprop-1-en-2-yl)thiophene (14) (Table 3, Entry 7)
General procedure IV was followed with Pd 2 dba 3 (11.4 mg, 0.025 mmol), IPr* OMe ·HBF 4 5b (25.8 mg, 0.025 mmol), t-BuOK (2.8 mg, 0.025 mmol), dimethylethoxysilane (68.8 µL, 0.5 mmol), cyclohexylallene (72.7 µL, 0.5 mmol), 2-iodothiophene (105 mg, 0.5 mmol), TBAF (1 mL, 1 mmol), and a second batch of Pd 2 dba 3 (11.4 mg, 0.025 mmol). The crude residue was purified by flash chromatography (100% hexanes) affording a clear oil (80 mg, 77 %). 1 
Prop-2-ene-1,2-diyldibenzene (16) (Table 3, Entry 9)
General procedure IV was followed with Pd 2 dba 3 (11.4 mg, 0.025 mmol), IPr* OMe ·HBF 4 5b (25.8 mg, 0.025 mmol), t-BuOK (2.8 mg, 0.025 mmol), dimethylethoxysilane (68.8 µL, 0.5 mmol), phenylallene (58.1 mg, 0.5 mmol), iodobenzene (102 mg, 0.5 mmol), TBAF (1 mL, 1 mmol), and a second batch of Pd 2 dba 3 (11.4 mg, 0.025 mmol). The crude residue was purified by flash chromatography (100% hexanes) affording a clear oil (73.7 mg, 76 %). Spectral data matched that previously reported ( 1 H NMR spectrum is included below). THF (25 mL) was added to a solid mixture of IPr* OMe 5b (213 mg, 0.225 mmol) and Pd 2 dba 3 (103 mg, 0.112 mmol) at rt. After stirring for 10 min at rt, the reaction mixture turned bright red and dimethylethoxysilane (0.618 mL, 4.5 mmol) was added. The reaction mixture was stirred for 5 min at rt followed by dilution with THF (75 mL) and addition of undeca-1,2-diene (685 mg, 4.5 mmol) neat by syringe. The reaction mixture was stirred at rt for 2.5 h and the reaction was complete by observed consumption of starting material as determined by thin-layer chromatography. TBAF (6.75 mL, 6.75 mmol, 1.0 M in THF) was then added slowly by hand with a syringe over 5 minutes (caution, a strong exotherm is generated!) to the stirring solution. After 10 minutes at rt, iodobenzene (0.502 mL, 4.5 mmol) was added. The reaction vessel was then heated at 50 °C in an oil bath until the reaction was determined complete by the disappearance of iodide, within 1 h, as determined by thin-layer chromatography. The reaction mixture was filtered through silica gel eluting with 50% v/v EtOAc/hexanes. The solvent was removed in vacuo, and the crude residue was purified via flash column chromatography (100% hexanes) on silica gel to afford the desired product as a clear oil (910 mg, 88%). Spectral data matched that previously published ( 1 H NMR spectrum is included below). 
